Filing Details

Accession Number:
0000711377-21-000022
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-09-30 18:28:54
Reporting Period:
2021-09-29
Accepted Time:
2021-09-30 18:28:54
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
711377 Neogen Corp NEOG In Vitro & In Vivo Diagnostic Substances (2835) 382367843
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1517426 J. Steven Quinlan 620 Lesher Place
Lansing MI 48912
Vice President & Cfo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-09-29 5,700 $20.23 33,639 No 4 M Direct
Common Stock Disposition 2021-09-29 5,700 $44.05 27,939 No 4 S Direct
Common Stock Acquisiton 2021-09-30 12,964 $20.23 40,903 No 4 M Direct
Common Stock Acquisiton 2021-09-30 12,964 $43.69 27,939 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Common Stock (Right to Buy) Disposition 2021-09-29 5,700 $0.00 5,700 $20.23
Common Stock Common Stock (Right to Buy) Disposition 2021-09-30 12,964 $0.00 12,964 $20.23
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
241,832 2021-09-29 2021-10-29 No 4 M Direct
228,868 2021-09-29 2021-10-29 No 4 M Direct